Blog Archives - Page 4 of 5

What We Do

Intelligence

Horizon Scanning & Risk Assessments

Always be prepared by identifying threats that demand your attention, anticipating how they will impact your organization, and responding appropriately to your mandate.

Risk Analysis Toolkit

Leverage diverse global data assets on disease spread, outbreak suitability, population vulnerability and more to make high-stakes decisions with confidence

Predictive Intelligence

Anticipate what’s coming in the weeks, months and even years ahead with disease forecasts

Solutions for

Public Health

Safeguard your population against global outbreaks that can cause health, economic, and social disruption

Pharma & Life Sciences

Ensure your infectious disease countermeasures are deployed precisely where and when they are needed most

Global Enterprise

Protect your people, operations, supply chains and reputation from the disruptive effects of global outbreaks

Rising Uncertainty: Confronting the Impacts of ILIs and H5N1 in the U.S.

Read More →
Why BlueDot

Customer Stories

Discover customer stories and real-world case studies showcasing how our intelligence informs actions and decisions

Scientific Research

Explore our peer-reviewed scientific publications that advance knowledge on detecting, understanding, and controlling global outbreaks

Awards & Recognition

Read about our achievements spanning scientific and technological innovation, business growth, and fostering a great work environment

Mpox insights and intelligence

Read More →
Resources

Talks & Panels

Tune into our latest talks, webinars, and informative panel sessions to hear from global leaders engaging in thought provoking discussions while delving into pressing industry challenges

Reports, Whitepapers & e-Books

Access an array of valuable resources on the latest innovations in infectious disease intelligence

Blog

Stay up-to-date by engaging with our continuously updated collection of articles, insightful analyses, and diverse perspectives.

Subscribe to our Newsletters

Our bi-monthly and monthly newsletters are your definitive source for the latest insights on infectious disease intelligence worldwide!

Newsroom

Stay current with the latest press from BlueDot, intelligence-related news, and industry-related updates

Rising Uncertainty: Confronting the Impacts of ILIs and H5N1 in the U.S.

Read More →
About

Our Story

Learn about BlueDot’s founding story and how we’ve evolved to become the organization we are today

Our People

Meet the exceptional people who are the driving force behind our organization

Contact Us

We’d love to hear from you! Our philosophy is that our reach and impact in the world is extended by working with others who share our vision for a healthier, safer, and more resilient world!

Mpox insights and intelligence

Read More →
Careers
Log in
Book A Demo

Blog

Summer 2022: Unexpected Disease Activity

BlogAugust 22, 2022

Beyond monkeypox, BlueDot detected 15 unexpected infectious disease events in the summer of 2022 that could impact your community, workforces, and operations. See what we

Read article

2 BlueDot Rapid risk assessment measles in indonesia and hte philippines

Monkeypox declared a global public health emergency – what’s next?

BlogJuly 27, 2022

The latest WHO declaration of monkeypox as public health emergency of international concern (PHEIC) may sound familiar – the last time it happened, it was

Read article

Influenza spillover events on the rise

BlogJune 15, 2022

How infectious disease intelligence helps mitigate the risk of outbreaks Infections that crossover from animals to humans pose a serious concern to current and future

Read article

Global influenza activity: the trends, changes, and predictions you need to know

BlogMay 30, 2022

Are you ready for more active and severe flu seasons? Through our global disease surveillance engine and in-house epidemiology expertise, BlueDot takes a detailed look

Read article

How we’re predicting stable reopenings

BlogApril 30, 2021

The effective end of the COVID-19 pandemic will be staggered around the globe. As a small number of developed countries plan to reopen in summer

Read article

2 Blog Covid in Sub Saharan Africa Feature

COVID-19 in Sub-Saharan Africa

BlogMarch 4, 2021

Understanding the spread of COVID-19 in Sub-Saharan Africa — and Africa as a whole — has remained a challenge one year after the first case

Read article

UN recognizes BlueDot’s potential to transform tourism

BlogFebruary 22, 2021

We know tourism will be different after COVID-19. The question is, will it be better? By working to mitigate the risks of disease outbreaks, BlueDot

Read article

How predicting your airport choice helps us fight disease outbreaks

BlogJanuary 18, 2021

Imagine you live in Boca Raton, Florida, and you are planning to fly to New York City. Will you book a flight from West Palm

Read article

The state of dengue during the COVID-19 pandemic

BlogJanuary 15, 2021

Dengue fever, a viral disease transmitted by Aedes mosquitoes, has increased in incidence and geographic range over the past decade. In this COVID-19 Focus Report, we explore the

Read article

2 Blog An update on COVID 19 vaccine candidates in Phase 3 clinical trials Feature

An update on COVID-19 vaccine administration and candidates in Phase 3 clinical trials

BlogJanuary 14, 2021

Vaccination campaigns against COVID-19 continue around the world, while new vaccine candidates are expected to complete Phase 3 clinical trials within the month. Our latest COVID

Read article

←1 2 3 4 5 →

X-twitter Linkedin 2018 B Corp Logo Black

By using this website, you accept our Privacy Policy. Site Map

Go to Top

Fill out the form below to learn more about sponsorship opportunities.

Doe Kley, RN, MPH, T-CHEST-LTC-CIP, CIC

Infection Prevention Fellow

Clorox Healthcare

Doe Kley is an Infection Prevention Fellow within Clorox Healthcare’s Clinical and Scientific Affairs team and is passionate about helping glean insights and solutions to tackle the many challenges faced in infection prevention. Her role focuses on providing consultative services and developing practice tools using her 20+ years of clinical expertise in acute care infection prevention from working in large healthcare systems, such as Intermountain Healthcare and Kaiser Permanente.

Doe is a registered nurse and received her Master of Public Health from the University of Nevada, as well as a Bachelor of Microbiology from Weber State University. She teaches an infection control course for the Ohio State University (OSU) and is also dual-board certified in infection prevention and epidemiology in both acute and long-term care. Additionally, Doe is certified to train EVS through Association for the Healthcare Environment (AHE) and is currently a member of AHE, the Association for Professionals in Infection Control & Epidemiology (APIC), the Association of periOperative Registered Nurses (AORN), and the Society for Healthcare Epidemiology of America (SHEA). Doe is active on several committees including Test Committee for the Certification Board of Infection Control & Epidemiology (CBIC) and the Advisory Council for the Pearce Foundation Environmental Services Optimization Playbook (EvSOP). She also served on the board of directors for California APIC Coordinating Council (CACC) in 2022.

Peter Ruestow, PhD

Director of Epidemiology

Chicago Department of Public Health

Bio coming soon!

Dr. Kamran Khan

Founder & CEO

BlueDot

Dr. Kamran Khan is an infectious disease physician-scientist and a Professor of Medicine and Public Health at the University of Toronto. Motivated by his experiences as a frontline healthcare worker during the 2003 Toronto SARS outbreak, Dr. Khan has been studying outbreaks of emerging and reemerging diseases for more than a decade to lay the scientific foundation for a global early warning system for infectious diseases. His research has been published in scientific journals from the New England Journal of Medicine, to the Lancet, Science, and Nature. To translate and disseminate scientific knowledge into timely action, Dr. Khan founded BlueDot in 2013, a digital health company that combines human and artificial intelligence to help governments protect their citizens, hospitals protect their staff and patients, and businesses protect their employees and customers from dangerous infectious diseases. His work during global health emergencies has led him into numerous advisory roles from the World Health Organization to the White House. Dr. Khan also received a Governor General’s Award for his work transcending clinical medicine, public health, big data, and artificial intelligence.

Dr. Philip Huang

Director and Health Authority

Dallas County Health and Human Services Department

Dr. Huang has been the Director and Health Authority for the Dallas County Health and Human Services (DCHHS) Department since February 2019. He received his undergraduate degree in Civil Engineering from Rice University, his MD from the University of Texas Southwestern Medical School, and his Master’s in Public Health from Harvard. Dr. Huang completed his residency training in Family Medicine at Brackenridge Hospital in Austin and was Chief Resident during his final year. He served two years as an Epidemic Intelligence Service (EIS) officer with the Centers for Disease Control and Prevention assigned to the Illinois Department of Public Health where he conducted epidemiologic studies in chronic disease and infectious disease outbreak investigations. Dr. Huang was Chief of the Bureau of Chronic Disease and Tobacco Prevention at the Texas Department of Health/Texas Department of State Health Services for 16 years and then served as Medical Director/ Health Authority at the Austin Public Health Department prior to moving to Dallas.

Dr. Huang has overseen epidemiologic and surveillance teams, and has also developed and implemented numerous surveillance systems at the state and local levels. Dr. Huang has served as Executive Project Lead for all of the DCHHS Data Modernization efforts. He is currently on the Board of the National Association of County and City Health Officials, and is the Immediate Past-Chair of the Big Cities Health Coalition. Dr. Huang is an Adjunct Assistant Professor with the University of Texas School of Public Health and also with the University of Texas Southwestern Medical School Peter O’Donnell Jr. School of Public Health.

Andrea Thomas, PhD, DVM

Head of Epidemiology

BlueDot

Dr. Andrea Thomas is a veterinarian with an MSc and PhD in epidemiology from the University of Guelph in Canada. Her interests lie at the intersections of global health, infectious diseases, and surveillance. She currently directs the epidemiology program at BlueDot, ensuring high quality data and information are shared in a timely manner with diverse stakeholders. Dr. Thomas was involved in the development of BlueDot’s global infectious diseases event-based surveillance system, which was instrumental in the early detection and monitoring of the COVID-19 pandemic. She has led BlueDot’s surveillance and epidemiology team of expert analysts through the development, maintenance, and dissemination of global COVID-19 data and information throughout the pandemic as they continued to track the spread of many other infectious diseases occurring globally.

Dr. Mariana Portillo Torres

Head of Infectious Disease Surveillance

BlueDot

Dr. Mariana Torres is a physician and currently leads BlueDot’s Surveillance team. With a comprehensive background in clinical and research work, Mariana’s prior experience includes significant contributions to Clinical Infectious Diseases at the Hospital for Sick Children and the University of Toronto in Canada. She completed the Infectious Diseases Research Program at Universidad Alcala de Henares and earned a Master’s degree in Immunology and Biology from Universidad del Zulia, Venezuela. Her academic foundation includes a Medical Doctor (Surgeon), and Paediatrics and Childcare post-graduate degree from the same institution. More recently she has obtained an Antimicrobial Resistance Certification from the London School of Hygiene & Tropical Medicine.

At BlueDot, Mariana has been instrumental in shaping BlueDot’s surveillance program, enhancing the utilization of AI for detecting and assessing emerging threats, and fostering innovation in the response to disease outbreaks.

Intelligence

Solutions for

Category

Blog

Doe Kley, RN, MPH, T-CHEST-LTC-CIP, CIC

Infection Prevention Fellow

Clorox Healthcare

Peter Ruestow, PhD

Director of Epidemiology

Chicago Department of Public Health

Dr. Kamran Khan

Founder & CEO

BlueDot

Dr. Philip Huang

Director and Health Authority

Andrea Thomas, PhD, DVM

Head of Epidemiology

BlueDot

Dr. Mariana Portillo Torres

Head of Infectious Disease Surveillance

BlueDot